Compare PRDO & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRDO | HTFL |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | 843 |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.2B |
| IPO Year | 1997 | N/A |
| Metric | PRDO | HTFL |
|---|---|---|
| Price | $34.00 | $28.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $42.00 | $38.20 |
| AVG Volume (30 Days) | 770.4K | ★ 1.0M |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | ★ 10.50 | N/A |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $581,296,000.00 | N/A |
| Revenue This Year | $4.28 | $27.66 |
| Revenue Next Year | $2.89 | $23.55 |
| P/E Ratio | $38.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.66 | $20.13 |
| 52 Week High | $38.50 | $41.22 |
| Indicator | PRDO | HTFL |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 51.38 |
| Support Level | $31.43 | $25.56 |
| Resistance Level | $32.79 | $32.69 |
| Average True Range (ATR) | 1.40 | 1.28 |
| MACD | 0.14 | 0.45 |
| Stochastic Oscillator | 60.07 | 90.83 |
Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.